101 related articles for article (PubMed ID: 7499862)
1. IL-10 is involved in the protective effect of dibutyryl cyclic adenosine monophosphate on endotoxin-induced inflammatory liver injury.
Arai T; Hiromatsu K; Kobayashi N; Takano M; Ishida H; Nimura Y; Yoshikai Y
J Immunol; 1995 Dec; 155(12):5743-9. PubMed ID: 7499862
[TBL] [Abstract][Full Text] [Related]
2. Protection by a cyclic AMP-specific phosphodiesterase inhibitor, rolipram, and dibutyryl cyclic AMP against Propionibacterium acnes and lipopolysaccharide-induced mouse hepatitis.
Taguchi I; Oka K; Kitamura K; Sugiura M; Oku A; Matsumoto M
Inflamm Res; 1999 Jul; 48(7):380-5. PubMed ID: 10450787
[TBL] [Abstract][Full Text] [Related]
3. The resistance of P. acnes--primed interferon gamma-deficient mice to low-dose lipopolysaccharide-induced acute liver injury.
Shimizu Y; Margenthaler JA; Landeros K; Otomo N; Doherty G; Flye MW
Hepatology; 2002 Apr; 35(4):805-14. PubMed ID: 11915026
[TBL] [Abstract][Full Text] [Related]
4. Dibutyryl cyclic AMP protects Corynebacterium parvum-treated mice against lipopolysaccharide-induced lethal toxicity.
Inoue H; Takahashi S; Nomoto K; Yoshikai Y
Cell Immunol; 1995 Apr; 162(1):1-7. PubMed ID: 7704897
[TBL] [Abstract][Full Text] [Related]
5. IL-18 accounts for both TNF-alpha- and Fas ligand-mediated hepatotoxic pathways in endotoxin-induced liver injury in mice.
Tsutsui H; Matsui K; Kawada N; Hyodo Y; Hayashi N; Okamura H; Higashino K; Nakanishi K
J Immunol; 1997 Oct; 159(8):3961-7. PubMed ID: 9378984
[TBL] [Abstract][Full Text] [Related]
6. Involvement of neutrophil recruitment and protease-activated receptor 2 activation in the induction of IL-18 in mice.
Ikawa K; Nishioka T; Yu Z; Sugawara Y; Kawagoe J; Takizawa T; Primo V; Nikolic B; Kuroishi T; Sasano T; Shimauchi H; Takada H; Endo Y; Sugawara S
J Leukoc Biol; 2005 Nov; 78(5):1118-26. PubMed ID: 16260585
[TBL] [Abstract][Full Text] [Related]
7. Roles of CD14 in LPS-induced liver injury and lethality in mice pretreated with Propionibacterium acnes.
Shuto Y; Kataoka M; Higuchi Y; Matsuura K; Hijiya N; Yamamoto S
Immunol Lett; 2004 Jun; 94(1-2):47-55. PubMed ID: 15234535
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor 2 mediates inflammatory cytokine induction but not sensitization for liver injury by Propioni- bacterium acnes.
Romics L; Dolganiuc A; Velayudham A; Kodys K; Mandrekar P; Golenbock D; Kurt-Jones E; Szabo G
J Leukoc Biol; 2005 Dec; 78(6):1255-64. PubMed ID: 16204620
[TBL] [Abstract][Full Text] [Related]
9. Effect of amodiaquine, a histamine N-methyltransferase inhibitor, on, Propionibacterium acnes and lipopolysaccharide-induced hepatitis in mice.
Yokoyama A; Mori S; Takahashi HK; Kanke T; Wake H; Nishibori M
Eur J Pharmacol; 2007 Mar; 558(1-3):179-84. PubMed ID: 17222819
[TBL] [Abstract][Full Text] [Related]
10. Dibutyryl cyclic adenosine monophosphate protects mice against tumor necrosis factor-alpha-induced hepatocyte apoptosis accompanied by increased heat shock protein 70 expression.
Takano M; Arai T; Mokuno Y; Nishimura H; Nimura Y; Yoshikai Y
Cell Stress Chaperones; 1998 Jun; 3(2):109-17. PubMed ID: 9672246
[TBL] [Abstract][Full Text] [Related]
11. Propionibacterium acnes treatment diminishes CD4+ NK1.1+ T cells but induces type I T cells in the liver by induction of IL-12 and IL-18 production from Kupffer cells.
Matsui K; Yoshimoto T; Tsutsui H; Hyodo Y; Hayashi N; Hiroishi K; Kawada N; Okamura H; Nakanishi K; Higashino K
J Immunol; 1997 Jul; 159(1):97-106. PubMed ID: 9200444
[TBL] [Abstract][Full Text] [Related]
12. Involvement of CD14 in lipopolysaccharide- induced liver injury in mice pretreated with Propionibacterium acnes.
Uchida T; Kataoka M; Higuchi Y; Matsuura K; Hijiya N; Yamamoto S
Pathobiology; 2004; 71(5):246-52. PubMed ID: 15459483
[TBL] [Abstract][Full Text] [Related]
13. IL-18-deficient mice are resistant to endotoxin-induced liver injury but highly susceptible to endotoxin shock.
Sakao Y; Takeda K; Tsutsui H; Kaisho T; Nomura F; Okamura H; Nakanishi K; Akira S
Int Immunol; 1999 Mar; 11(3):471-80. PubMed ID: 10221659
[TBL] [Abstract][Full Text] [Related]
14. Suppression of tumor necrosis factor alpha production by cAMP in human monocytes: dissociation with mRNA level and independent of interleukin-10.
Shames BD; McIntyre RC; Bensard DD; Pulido EJ; Selzman CH; Reznikov LL; Harken AH; Meng X
J Surg Res; 2001 Aug; 99(2):187-93. PubMed ID: 11469886
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-10 does not mediate the inhibitory effect of PDE-4 inhibitors and other cAMP-elevating drugs on lipopolysaccharide-induced tumors necrosis factor-alpha generation from human peripheral blood monocytes.
Seldon PM; Barnes PJ; Giembycz MA
Cell Biochem Biophys; 1998; 29(1-2):179-201. PubMed ID: 9631245
[TBL] [Abstract][Full Text] [Related]
16. A pivotal role of IL-12 in Th1-dependent mouse liver injury.
Tanaka Y; Takahashi A; Watanabe K; Takayama K; Yahata T; Habu S; Nishimura T
Int Immunol; 1996 Apr; 8(4):569-76. PubMed ID: 8671644
[TBL] [Abstract][Full Text] [Related]
17. Administration of interleukin-10 at the time of priming protects Corynebacterium parvum-primed mice against LPS- and TNF-alpha-induced lethality.
Smith SR; Terminelli C; Denhardt G; Narula S; Thorbecke GJ
Cell Immunol; 1996 Nov; 173(2):207-14. PubMed ID: 8912878
[TBL] [Abstract][Full Text] [Related]
18. IFN-gamma is a master regulator of endotoxin shock syndrome in mice primed with heat-killed Propionibacterium acnes.
Kawa K; Tsutsui H; Uchiyama R; Kato J; Matsui K; Iwakura Y; Matsumoto T; Nakanishi K
Int Immunol; 2010 Mar; 22(3):157-66. PubMed ID: 20130231
[TBL] [Abstract][Full Text] [Related]
19. Curcumin attenuated acute Propionibacterium acnes-induced liver injury through inhibition of HMGB1 expression in mice.
Gu Q; Guan H; Shi Q; Zhang Y; Yang H
Int Immunopharmacol; 2015 Feb; 24(2):159-165. PubMed ID: 25510585
[TBL] [Abstract][Full Text] [Related]
20. Alleviation of lipopolysaccharide-induced acute liver injury in Propionibacterium acnes-primed IFN-gamma-deficient mice by a concomitant reduction of TNF-alpha, IL-12, and IL-18 production.
Tsuji H; Mukaida N; Harada A; Kaneko S; Matsushita E; Nakanuma Y; Tsutsui H; Okamura H; Nakanishi K; Tagawa Y; Iwakura Y; Kobayashi K; Matsushima K
J Immunol; 1999 Jan; 162(2):1049-55. PubMed ID: 9916732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
